Monograph Details

Central Nervous System > ADHD/narcolepsy
METHYLIN CHEWABLE
Manufacturer
Alliant Pharmaceuticals, Inc.
Legal Classification
CII
Pharmacological Class
Stimulant.
Generic Name
Methylphenidate HCl 2.5mg, 5mg, 10mg; chew tabs; grape flavor; contains phenylalanine.
Also
METHYLIN
METHYLIN ER
METHYLIN ORAL SOLUTION
Indications
Attention deficit hyperactivity disorder. Narcolepsy.
Children
<6yrs: not recommended. ≥6yrs: initially 5mg twice a day before breakfast and lunch. Increase gradually by 5–10mg per week if needed; max 60mg daily.
Adults
10–60mg daily in 2–3 divided doses preferably 30–45 minutes before meals.
Contraindications
During or within 14 days of MAOIs. Marked anxiety, tension, agitation. Glaucoma. History of tics or Tourette's syndrome in patient or family.
Precautions
Discontinue if seizures or agitation occur. Reduce dose or discontinue if paradoxical excitement occurs. Reassess periodically. Reevaluate therapy at puberty. Hypertension. Psychosis. Seizure disorders. Depression. Normal fatigue states. Emotionally unstable (e.g., drug or alcohol abusers). Abuse potential. May exacerbate behavior disturbances, thought disorders. Monitor growth, blood pressure, CBC, differential, and platelet counts. Pregnancy or women of childbearing potential: not recommended.
Interactions
See Contraindications. Caution with pressor agents, anticonvulsants, α2-agonists (eg, clonidine). May increase levels of anticonvulsants, oral anticoagulants, tricyclics, phenylbutazone. Antagonizes guanethidine, other antihypertensives.
Adverse Reactions
Insomnia, nervousness, CNS overstimulation, anorexia, weight loss, abdominal pain, nausea, dizziness, headache, dyskinesias, hypertension, tachycardia, arrhythmias, Tourette's syndrome, toxic psychosis, seizures, blood dyscrasias, rash, visual disturbances.
How Supplied
Tabs—100, 1000
Chews tabs—100
Oral soln—500mL
ER—100
Additional Resources
Related Prescribing Note